Western blot analyses and immunofluorescence staining showed that colchicine treatment increased the expression of α-SMA (a marker of VSMCs contractile phenotype) and suppressed the expression of OPN (a marker of VSMCs synthetic phenotype) after AAA induction (Figure 2A,B). This evidence concerns the gene ACTA1 and triple-A syndrome.